Literature DB >> 18469537

Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.

Paola Maccioni1, Daniela Pes, Mauro A M Carai, Gian Luigi Gessa, Giancarlo Colombo.   

Abstract

Pharmacological blockade of the cannabinoid CB1 receptor has been repeatedly reported to suppress intake of food, including highly palatable foods, in laboratory animals. This study was designed to investigate whether treatment with the cannabinoid CB1 receptor antagonist, rimonabant, would reduce the reinforcing and motivational properties of a chocolate-flavoured beverage [containing 5% (w/v) chocolate powder] in nonfood-deprived and nonwater-deprived Wistar rats trained to self-administer this beverage under an operant conditioning procedure. This study was also aimed at assessing to what degree self-administration behaviour could be manipulated environmentally. After a period of training and maintenance of the self-administration behaviour, separate groups of rats were exposed to different experimental conditions [session length varying from 20 to 120 min; fixed ratio (FR) schedule of reinforcement varying from FR10 to FR40; reinforcer presentation varying from 2.5 to 10 s; concentration of the chocolate powder varying from 5% (w/v) to 0%]; other rat groups were used to test the effect of acute and repeated treatment with rimonabant (1-5.6 mg/kg, intraperitoneally) on two schedules of reinforcement (FR10 and progressive ratio) and extinction responding. All rats rapidly acquired and steadily maintained high levels of self-administration of the chocolate-flavoured beverage. Changes in experimental conditions modified the rats' self-administration behaviour; these changes seemed to be the result of the rats' attempt to adjust their behaviour so as to consume as much of the chocolate-flavoured beverage as possible when it was presented at its most palatable 5% concentration. Treatment with rimonabant dose-dependently suppressed self-administration of the chocolate-flavoured beverage. When rimonabant was administered repeatedly, only a modest degree of tolerance developed to its reducing effect. Finally, treatment with rimonabant resulted in a dose-dependent reduction of the motivational properties of the chocolate-flavoured beverage, measured by the progressive ratio schedule of reinforcement and extinction-responding procedure. These results suggest that self-administration of a chocolate-flavoured beverage can be rapidly and reliably established in rats and that this behaviour is environmentally manipulable. These results also suggest that the cannabinoid CB1 receptor is a crucial component of the neural substrate mediating the reinforcing and motivational properties of a highly palatable food such as a chocolate-flavoured beverage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469537     DOI: 10.1097/FBP.0b013e3282fe8888

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  17 in total

1.  Binge drinking in alcohol-preferring sP rats at the end of the nocturnal period.

Authors:  Giancarlo Colombo; Paola Maccioni; Carla Acciaro; Carla Lobina; Barbara Loi; Alessandro Zaru; Mauro A M Carai; Gian Luigi Gessa
Journal:  Alcohol       Date:  2014-03-01       Impact factor: 2.405

2.  Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats.

Authors:  E J Marijke Achterberg; Maaike M H van Swieten; Nina V Driel; Viviana Trezza; Louk J M J Vanderschuren
Journal:  Pharmacol Res       Date:  2016-05-03       Impact factor: 7.658

3.  Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors.

Authors:  Paola Maccioni; Giancarlo Colombo; Irene Lorrai; Alessandro Zaru; Mauro A M Carai; Gian Luigi Gessa; Antonella Brizzi; Claudia Mugnaini; Federico Corelli
Journal:  Psychopharmacology (Berl)       Date:  2017-05-24       Impact factor: 4.530

4.  Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-Like Behavior.

Authors:  Samantha Mancino; Aurelijus Burokas; Javier Gutiérrez-Cuesta; Miriam Gutiérrez-Martos; Elena Martín-García; Mariangela Pucci; Anastasia Falconi; Claudio D'Addario; Mauro Maccarrone; Rafael Maldonado
Journal:  Neuropsychopharmacology       Date:  2015-05-06       Impact factor: 7.853

5.  Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats.

Authors:  Giovanni Hernandez; Joseph F Cheer
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

6.  Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence.

Authors:  Alexander Neumeister; Marc D Normandin; James W Murrough; Shannan Henry; Christopher R Bailey; David A Luckenbaugh; Keri Tuit; Ming-Qiang Zheng; Isaac R Galatzer-Levy; Rajita Sinha; Richard E Carson; Marc N Potenza; Yiyun Huang
Journal:  Alcohol Clin Exp Res       Date:  2012-05-02       Impact factor: 3.455

7.  Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test.

Authors:  Maria Flavia Barbano; Anna Castañé; Elena Martín-García; Rafael Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2009-05-19       Impact factor: 4.530

8.  Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.

Authors:  Benoit Forget; Kathleen M Coen; Bernard Le Foll
Journal:  Psychopharmacology (Berl)       Date:  2009-05-30       Impact factor: 4.530

9.  A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions.

Authors:  Laura Orio; Scott Edwards; Olivier George; Loren H Parsons; George F Koob
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

10.  Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers.

Authors:  Luke Tudge; Clare Williams; Philip J Cowen; Ciara McCabe
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-25       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.